(S)-1-((S)-1-Phenyl-2-pyrrolidin-1-yl-ethyl)-3-(4-trifluoromethyl-phenyl)-1,3,4,7-tetrahydro-azepin-2-one

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-1-((S)-1-Phenyl-2-pyrrolidin-1-yl-ethyl)-3-(4-trifluoromethyl-phenyl)-1,3,4,7-tetrahydro-azepin-2-one
• 英文别名: (6S)-1-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]-6-[4-(trifluoromethyl)phenyl]-5,6-dihydro-2H-azepin-7-one
• 化学式: C₂₅H₂₇F₃N₂O
• 分子量: 428.497
• InChiKey: ASGNSBZVWDMQMJ-XZOQPEGZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  31
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  23.6
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  2-(4-Trifluoromethyl-phenyl)-pent-4-enoic acid allyl-((S)-1-phenyl-2-pyrrolidin-1-yl-ethyl)-amide; hydrochloride 在 RuCl2(1,3-dimesityl-imidazolidin-2-yl)(PCy3)(=CHPh) 作用下， 以 二氯甲烷 为溶剂， 生成 (R)-1-((S)-1-Phenyl-2-pyrrolidin-1-yl-ethyl)-3-(4-trifluoromethyl-phenyl)-1,3,4,7-tetrahydro-azepin-2-one 、 (S)-1-((S)-1-Phenyl-2-pyrrolidin-1-yl-ethyl)-3-(4-trifluoromethyl-phenyl)-1,3,4,7-tetrahydro-azepin-2-one
  参考文献：
  名称：

  Azepinone as a conformational constraint in the design of κ-opioid receptor agonists

  摘要：

  A new class of kappa-opioid receptor agonists is described. The design of these agents was based upon energy minimization and structural overlay studies of the generic azepin-2-one structure 3 with the crystal structure of arylacetamide kappa agonist 1, ICI 199441. The most active compound identified was ligand 4a (K-i = 0.34 nM), which demonstrated potent antinociceptive activity after oral administration in rodents. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.08.041

文献信息

• Azepinone as a conformational constraint in the design of κ-opioid receptor agonists
  作者：Paul A. Tuthill、Pamela R. Seida、William Barker、Joel A. Cassel、Serge Belanger、Robert N. DeHaven、Michael Koblish、Susan L. Gottshall、Patrick J. Little、Diane L. DeHaven-Hudkins、Roland E. Dolle

  DOI：10.1016/j.bmcl.2004.08.041

  日期：2004.11

  A new class of kappa-opioid receptor agonists is described. The design of these agents was based upon energy minimization and structural overlay studies of the generic azepin-2-one structure 3 with the crystal structure of arylacetamide kappa agonist 1, ICI 199441. The most active compound identified was ligand 4a (K-i = 0.34 nM), which demonstrated potent antinociceptive activity after oral administration in rodents. (C) 2004 Elsevier Ltd. All rights reserved.